Mead Johnson Nutrition (NYSE: MJN) reported earnings on April 25. Here are the numbers you need to know.

The 10-second takeaway For the quarter ended March 31 (Q1), Mead Johnson Nutrition beat slightly on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue grew. GAAP earnings per share grew.

Gross margins increased, operating margins dropped, net margins were steady.

Revenue details Mead Johnson Nutrition reported revenue of $1.04 billion. The 11 analysts polled by S&P Capital IQ anticipated sales of $1.02 billion on the same basis. GAAP reported sales were 5.2% higher than the prior-year quarter's $986.6 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details EPS came in at $0.85. The 14 earnings estimates compiled by S&P Capital IQ anticipated $0.85 per share. GAAP EPS of $0.85 for Q1 were 6.3% higher than the prior-year quarter's $0.80 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details For the quarter, gross margin was 62.3%, 20 basis points better than the prior-year quarter. Operating margin was 24.0%, 200 basis points worse than the prior-year quarter. Net margin was 16.6%, much about the same as the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead Next quarter's average estimate for revenue is $1.04 billion. On the bottom line, the average EPS estimate is $0.83.

See the rest here:
Mead Johnson Nutrition Beats on Revenue, Matches Expectations on EPS